Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Gus Monsanto his career, a very hard and wear a disappointment so great that Monsanto did admit the possibility of giving up the dream to continue making music. But when all seemed lost, Monsanto sees the announcement of banda French Adagio, which featured one of his favorite singers, David Readman (PINK CREAM 69). David had just left the band, which was seeking a replacement immediately. Half curious, half for refusing to believe that was the end of the line, Monsanto had his material. However, for geographical reasons, even he did not expect a return. Then came the surprise: he receives an email